A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and gentamicin) changed, and whether there was any relationship between GNO susceptibility to these antimicrobials and ciprofloxacin usage.
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
Troughton, J. A., Millar, G., Smyth, E. T. M., Doherty, L., & McMullan, R. (2011). Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics. Journal of Antimicrobial Chemotherapy, 66(9), 2152-8. [dkr264]. https://doi.org/10.1093/jac/dkr264